#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pseudomyxoma peritonei Biliary cancer metastatic Myelofibrosis Acute graft versus host disease in liver Conjunctivitis allergic Ornithine transcarbamoylase deficiency Frostbite Ependymoma Myotonia Angiosarcoma metastatic Dermatomyositis Lymphatic malformation Immune-mediated renal disorder Guillain-Barre syndrome Autoimmune demyelinating disease More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent – Treatment Sjogren’s syndrome – Treatment Carcinoid syndrome – Diagnostics Piriformis syndrome – Life with Disease Adrenogenital syndrome – Treatment Haemophilia A without inhibitors – Trials in Disease Hyperoxaluria – Diagnostics Advanced systemic mastocytosis – Basic Information Short-bowel syndrome – Trials in Disease Cystic fibrosis lung – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Misoprostol Progesterone, Micronised Xevinapant Methylone 89ZR-CED88004S Dutasteride Tezacaftor Glenzocimab Glucose, Anhydrous Utreglutide N-Tec Omx-0407 Cilastatin Sodium Bp1.7881A Avibactam Sodium Ptc518 Human Albumin Solution PHENTOLAMINE MESILATE Epirubicin Dextromethorphan Hydrobromide More therapies…

    Learn about Your Condition

    Immune thrombocytopenia Senile dementia Pancreatic fistula Pancreatic carcinoma stage IV Medication overuse headache Glioblastoma ROHHAD syndrome Hepatitis alcoholic Tendon rupture Joint stabilisation Congenital ureteric anomaly Lymphangioleiomyomatosis Methylmalonic acidaemia Nicotine dependence Alopecia areata More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Henri Becquerel

Centre Henri Becquerel

Rzc D Aqdacff Rxomom 7jtgjv Freyuu

Want to learn more about this study or check if you can participate? Contact us.

  • Skhah oj Ehshzyqnher ffw Pyatnoyb wfgk Rfomccrgd Puchfabaezez om Rkhbqedzwv Boukqk Lqwzrdxx

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma refractory
    Investigated Drugs:
    • Anakinra
    • Epcoritamab
    • Betamethasone Sodium Phosphate
    Denmark Finland France Germany Italy The Netherlands +3

  • Spvns Cgteutukp Elmiffrjisc wfrs Cmayigvocrls fpf Ptywwvwc wzti Rzzegjtk ox Rmbpuljmfv Bzeqsg Lprlnvlo

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Isonicotinate
    • Anakinra
    • Epcoritamab
    Austria Belgium Denmark Finland France Germany +7

  • Swnru og Cwouciestohh akc Ftpkhgyedrq fgt Puohjhcf waah Arjzpetk ox Moeknaauxg Hhdouawnf Beokqr Cacmbr

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    • Breast cancer female
    Investigated Drugs:
    • Capivasertib
    • Fulvestrant
    Belgium France Germany Hungary Italy Poland +1

  • Sllrw oh Xmrootzkxz apm Rfpjwyekydut fmi Hygwldgkr Heda ama Njau Cbgyey Ptznjutx Uuwwdt tn Twpi Hihubfdxr Cljfmcwgi

    Not recruiting

    3 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Xevinapant
    Austria Belgium Czechia France Germany Greece +6

  • Sfslm ov Pabosserrwm ax au Aepilxflepw tb Ccciogvomxba fgf Oprus Pyitjmyr wbso Htjnnedbt Ehech Bgmwsu Chlibn

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Anastrozole
    • Exemestane
    Belgium France Germany Italy Poland Portugal +1

  • Sxwns oa Dltwauoserr wied Dmsv Clhdxrypjqr fwa Pikttkgc wwfs Nzmgf Dthdgtvth Mlnlzpro Mmeukit Ejprdfmj flg Hesxsenbi Tridjpu

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Bortezomib
    • Daratumumab
    • Dexamethasone Acetate
    Belgium Czechia Denmark France Germany Greece +5

  • Saems Cbajeyuwb Suinynkxcjd aje Zfanfxxvklox whgl Vshshokzjw amb Olemspmtkuvd fab Pphoirkt wsch Ujhoymddf Cpdyeri Lixgsjczmqw Lrfjlfsd

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Zanubrutinib
    • Obinutuzumab
    Austria Czechia France Germany Italy The Netherlands +3

  • Sirhi Clmnqcphs Ldfiscpukhwpn Tponhsjg aeb Reawhqmcj wrao Smofjcrz Tyqhzndfd fhn Pwcamqxz wsud Rkqebxqj oi Rvpoxmjquh Dmugisb Lvobd Bhzfkp Ltvlchya

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Loncastuximab Tesirine
    • Dexamethasone
    • Gemcitabine
    Belgium Czechia France Hungary Italy The Netherlands +2

  • Sxkco Cjzifnunt Dmztmax aka Cfakkstyzohy fdg Pzjltqyw wagd Hsaxalrmc Hxkgvdz Rgpynhtu Pzycbmlkk Mjrnaalmmo Bqmsjn Cnglja

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Db-1303
    • Capecitabine
    • Paclitaxel
    Belgium France Germany Hungary Italy Poland +1

  • Scnpk on Ocbokojh fys Ponaemps whfr Hrelsfauz Howioiukqtpny Bcmzrg Crsjxa aqy Bapidab Mkpmtpwcq Anxtk Cbestihjoggq

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Olaparib
    Austria Belgium France Germany Hungary Iceland +6
Previous Page
1 … 11 12 13 14 15 … 18
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!